Introduction
The human Rad51 gene, HsRAD51, is a homolog of RecA of Escherichia coli (Shinohara et al. 1993 ) and functions in DNA repair and recombination (Resnick 1987; Shinohara et al. 1992) . Rad51 shares many biochemical properties with RecA. It binds to single-and double-stranded DNA, exhibits DNA-dependent adenosine triphosphatase (ATPase) activity, forms helical nucleoprotein filaments, and mediates homologous pairing and strand exchange between DNA molecules (Benson et al. 1994; Baumann et al. 1996; Gupta et al. 1997) . The evolutionarily conserved Rad52 group of genes, of which the Rad51 gene is one, cotrols recombinational repair of DNA double-stranded breaks and other lesions in Saccharomyces cerevisiae. Rad51 protein performs crucial functions in this process (Game 1993) . Mutations in Rad51 cause reduced meiotic and mitotic recombination, hypersensitivity to ionizing radiation and methylmethanesulfonate, and a deficiency in the repair of DSBs.
The two major hereditary breast cancer susceptibility genes, BRCA1 and BRCA2, are associated with familial breast cancer, ovarian cancer, or both. Germline mutations in the BRCA1 gene increase the risk of development of early-onset breast cancer and ovarian cancer (Miki et al. 1994) . Alterations in the BRCA2 gene result in an increased risk of development of breast cancer in both women and men (Wooster et al. 1995) , and a moderately increased risk of a variety of other cancers including carcinomas of the ovary, pancreas, prostate, and colon (Gudmundsson et al.
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Subjects and methods

Subjects
Twenty unrelated families showing a pattern of inheritance of breast cancer were evaluated. For each family, a pedigree was prepared on the basis of a family member known to be affected. The criteria for selection of "breast-cancer families" for this study were as follows: (i) at least three first-degree family members with breast cancer, or (ii) two or more first-degree family members with breast cancer, either early-onset, bilateral, or accompanied by a history of primary cancer(s) of other organs. In addition, we selected 25 patients with breast cancer, either early-onset, bilateral, or accompanied by a history of primary cancer(s) of other organs, whose onset seemed to be associated with dysfunction of genetic factor(s). We obtained informed consent for the genetic study from these patients. Blood samples were obtained from affected family members and genomic DNAs were extracted from fresh blood under standard protocols (Sambrook et al. 1989 ).
Northern blot analysis
Human tissue blots, containing in each lane 2 µg poly (A)ϩ RNA from one of 16 different normal tissues (Clontech, Palo Alto, CA, USA) were hybridized with full-length cDNA of Rad51. Blots were prehybridized for 4 h and hybridized for 16 h at 42°C in a solution containing 50% formamide, 5 ϫ Denhardt, 5 ϫ saline sodium phosphate ethylenediaminetetraacetic acid (SSPE), 2% sodium dodecylsulfate (SDS), and 100 µg/ml of denatured salmon sperm DNA. The blots were washed in 2 ϫ saline sodium citrate (SSC) for 10 min at room temperature and twice in 0.1 ϫ SSC and 0.1% SDS, for 20 min each time, at 55°C before being autoradiographed at Ϫ80°C for 16 h.
SSCP analysis
The entire coding sequences of Rad51 and associated exonintron boundary sequences were examined by PCR-SSCP analysis. The primers used for PCR-SSCP analysis are described in Table 1 . Each genomic DNA (50 ng) was amplified in a reaction mixture containing 10 µl of 1 ϫ PCR buffer (25 mM N-tris [Hydroxymethyl] methyl-3-aminopropanesulfonic acid [TAPS] , 50 mM KCl, 2 mM MgCl2, and 1 mM beta-mercaptoethanol), 20µM dNTPs, 5 pmol primers, 2 µCi of [α-32 P]dCTP (3000 Ci/mmol; 10 mCi/ml), and 0.5 units of Taq polymerase (Takara, Kyoto, Japan). PCR conditions consisted of one cycle at 94°C for 2 min, then 30 cycles at 94°C for 30s, 55°C for 30 s, and 72°C for 30 s, with final elongation at 72°C for 5 min. Each reaction mixture was diluted with 50 µl of 95% formamide dye and 20 mM ethylenediaminetetraacetic acid (EDTA), incubated at 95°C for 5 min, and electrophoresed in a 6% polyacrylamide gel containing 5% glycerol and 0.5 ϫ TBE (90 mM Tris-borate/2 mM EDTA) maintained at 4°C and 16°C, under two different conditions: 400 V at 4°C and 1200 V at 16°C. The gel was dried and autoradiographed with an intensifying screen. When vari- TTCCACTAGGTAGAAGAATCT  183  55  3  TATCCATGGTTTTCTTCATTTG  TCCCTAGGTTAAGTAAGCAG  190  55  4  CAAGATCACTGTGGTAAGGAA  ACAACACAGGATAAAGGATTAC  202  55  5  ATGCTAAGAGTTATTTCTTATC  GATTAGCTATAGCCCCAACA  150  55  6  AAGATGTCATGAGGAGCTTGG  GCCATAGTCTCTCTTATCTAAACCAG  205  55  7  TTCTGTGTGCAGCCTAAAAAT  ACTCTTAAGAACATATTTGGTG  195  55  8  AATAGGCTTCAGAGAATCCTT  CTCTGTCCCTATCCCACAA  186  55  9  ATGGCCACAAAATTGACATTTA  CATTCCGAAAAGAAGAACTG  197  55  10  TTATAATAAATTGGTGCTTTGGT  TTTTAACAGAGGAAAAACCCAA  190  55 PCR-SSCP, Polymerase chain reaction-single-strand conformation polymorphism ant bands were detected on SSCP analysis, DNAs were amplified by PCR and electrophoresed on 2% agarose gel, extracted from the gel, and subcloned into pT7-BlueTVector (Novagen, Madison, WI, USA). At least 50 clones were pooled together and DNAs were extracted as sequence templates. Their nucleotide sequences were determined by dideoxy-chain termination with T7 DNA polymerase, using gene-specific primers to identify the nature of the mutation. All results were confirmed by two independent experiments.
Results
Northern blotting
As shown in Fig. 1A , hybridization of RNA blots to labeled fragment of Rad51 cDNA revealed a single transcript of approximately 2 kb. This transcript was most abundant in testis and thymus, but was also present in small intestine, placenta, colon, pancreas, and ovary. Expression of the Rad51 gene in breast tissues was confirmed by reverse transcription (RT)-PCR experiments (Fig. 1B) . The tissue expression pattern of the Rad51 gene was found to be closely similar to those of the BRCA1 and BRCA2 genes (Miki et al. 1994; Tavtigian et al. 1996) .
Mutation analysis of Rad51
Genomic DNAs were obtained from 20 patients in breast cancer families, and from 25 patients with breast cancers, either early-onset, bilateral, or accompanied by a history of primary cancer(s) of other organs, whose onset seemed to be associated with dysfunction of genetic factor(s). To evaluate whether the Rad51 gene was altered in patients with breast cancer, we screened the entire coding sequence and intronic sequences flanking each of its exons for mutations, using PCR-SSCP. Table 1 summarizes the primers used for the amplification of each single exon. The DNA sequences of PCR products obtained from DNAs corresponding to SSCP variants were determined.
Results revealed a single alteration in exon 6, which was determined to be present in the germline in two patients with bilateral breast cancers. Representative autoradiograms of PCR-SSCP and sequence analysis of the Rad51 gene in one of the two patients are shown in Fig. 2 . One patient was a 52-year-old woman with synchronous bilateral breast cancer (patient I, histopathology; noninvasive ductal carcinoma) and the other patient was a 44-year-old woman with synchronous bilateral multiple breast cancer (patient II, histopathology; invasive ductal carcinoma). Patient I had no family history of breast cancer, and the family history of patient II was unknown. In both patients, blood DNAs showed a G-to-A transition of the second nucleotide of codon 150, which results in the substitution of glutamine for arginine. The normal allele was present in these samples, indicating that the patients were heterozygous for the alteration. To examine two-hit inactivation, we analyzed the status of Rad51 alleles in the breast tumors of the two patients. Each of the genomic DNAs from tumor tissues was amplified by PCR and subcloned into pT7-BlueT-Vector. Ten clones from ten colonies were sequenced for codon 150 alteration of Rad51. In one case (patient II), we detected far more mutated alleles than normal alleles. Results were confirmed by three independent experiments. In consideration of normal tissue contamination, we concluded that patient II had loss of the normal allele. Furthermore, we screened for this base substitution in 200 patients with sporadic breast cancers and 100 patients with colon cancers. As this alteration was not detected in any patients examined, we assume that this missense alteration is likely to be a disease-causing mutation. Apart from this alteration, no other sequence variants were observed.
Discussion
Mutation of the BRCA1 gene is thought to be the causative factor in approximately 30% of hereditary breast cancer families. Moreover, the proportion of early-onset breast cancer accounted for by the BRCA2 and BRCA1 genes appears to be roughly equal (Couch et al. 1997; Noguchi et al. 1999) . The remaining susceptibility to early-onset breast cancer is likely attributable to unmapped genes for familial cancer and rare germline mutations in genes such as TP53 and PTEN (Srivastava et al. 1990; Malkin et al. 1990; Liaw et al. 1997 ). The isolation of unmapped genes responsible for the remaining susceptibility is important for the genetic testing of hereditary breast cancer, as well as for the understanding of breast carcinogenesis.
There is no direct evidence that cancer occurs through defects in repair processes involving homologous recombination. NBS1, a member of the hMRE11/Hrad50 recombination protein complex, was shown to be mutated in Nijmegen breakage syndrome, which is characterized by increased cancer incidence and ionizing radiation sensitivity (Varon et al. 1998; Carney et al. 1998; Matsuura et al. 1998) , suggesting that a defect in recombination leads to tumor development. Rad51 acts as a complex with breast cancer susceptibility gene products BRCA1 and BRCA2, and the tissue expression patterns of the three genes are very similar. These gene products participate in a common DNA damage response pathway. Components of this pathway would be required for the stability of genetic information, and their loss would be expected to result in an elevated mutation rate, and lead to the accumulation of DNA damage and, hence, to increased cancer risk.
Based on these considerations, we investigated here the possibility that Rad51 might be a breast cancer-predisposing gene, and detected one alteration of Rad51 in two patients with bilateral breast cancers. The amino acid substitution of a neutral residue (Gln) for a basic residue (Arg) detected here is reported as a missense mutation of the TP53 gene, and no sequence variants in Rad51 have been found previously (Schmutte et al. 1999; Bell et al. 1999 ). In addition, both patients with this alteration were diagnosed as having synchronous bilateral breast cancers, and this alteration was not present in more than 300 patients with breast or colon cancers. We therefore assume that this alteration is likely to represent a disease-associated mutation. Segregation or functional analysis should be performed to exclude the possibility that the nucleotide change is a rare polymorphism. Common genetic variations, including single base substitution, have recently assumed considerable importance, because even a modest increase in cancer risk associated with a polymorphism may be significant. The I1307K mutation in the APC gene is common in the Ashkenazi Jewish population and is associated with a moderately increased risk of colon cancer (Laken et al. 1997) . Even if the single base substitution described here is a rare polymorphism, it is possible that this alteration may be related to bilateral breast cancer. Further work will be required to determine whether this alteration displays any deficiency in DNA repair.
We have described the possibility that a small proportion of bilateral breast cancers is due to germline alterations of Rad51. However, the third major breast cancer susceptibility gene remains unknown; intense efforts will be required to isolate the gene(s) responsible. Fig. 2A-C . Representative autoradiograms of PCR-single-strand conformation polymorphism (SSCP) and sequence analysis of exon 6 in Rad51. A PCR-SSCP analysis of exon 6 in rad51 from patient I. (I). Arrow indicates the aberrant band. B Sequence analysis of exon 6 from normal control. C Sequence analysis of exon 6 from patient I
